Drugs / CMTS0929
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT06844708 | Feb 2025 → Jan 2030 expected | inflammatory bowel disease | The Second Hospital of Nanjing Medical University | Not yet recruiting | No outcome recorded |
| Phase 0 | NCT06836427 | Feb 2025 → Jan 2030 expected | Clostridium difficile colitis | The Second Hospital of Nanjing Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CMTS0929 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06844708 ↗ |
| Known as | China Microbiota Transplantation System 0929 | “China Microbiota Transplantation System 0929 (CMTS0929) is defined as suspension from washed microbiota.” NCT06844708 ↗ |
| Modality | Other / unclassified | “CMTS0929 is defined as suspension from washed microbiota.” NCT06836427 ↗ |
| Route | Other | “via colonic transendoscopic enteral tube (cTET)” NCT06836427 ↗ |